Indeed, the combination therapy led to a marked repression of tumor growth that was accompanied by the synergistic recruitment of CD4+ and CD8+ effector/memory T cells and CD8+ T cells with enhanced cytotoxic potential (Fig. 9d, e); the combination therapy also led to synergistic increases in other TILs including NK cells (Fig. 9f). This evidence concerns the gene CD8A and neoplasm.